Dataset Information

Functional performance improvement data and patent sets for 30 technology domains with measurements of patent centrality and estimations of the improvement rate.

ABSTRACT: This article accompanies the study presented in Triulzi et al. (2020) [1]. It briefly describes and makes available the data on functional performance for 30 technology domains, their patent sets, the measurement of patent centrality and the method to estimate the yearly technology performance improvement rate (TIR) that underly that study. Some of this data (performance time series and the lists of patents for 28 domains) has been collected by other authors for previous studies but were previously unavailable to the public. Measurements of patent centrality and other patent-based indicators for the 30 domains, and for 5.259.906 utility patents granted by the United States Patent and Trademark Office between 1976 and 2015 are novel data contributed by Triulzi et al. (2020) [1]. Here we organize, describe and make available the collection of data in its entirety. This allows anyone interested to replicate the study or use the method to estimate the improvement rate of a given technology for which patents can be identified. For a detailed description of the data and methods see Triulzi et al. (2020) [1].

SUBMITTER: Triulzi G

PROVIDER: S-EPMC7490809 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Functional performance improvement data and patent sets for 30 technology domains with measurements of patent centrality and estimations of the improvement rate.

Triulzi Giorgio G Magee Christopher L CL

Data in brief 20200902

This article accompanies the study presented in Triulzi et al. (2020) [1]. It briefly describes and makes available the data on functional performance for 30 technology domains, their patent sets, the measurement of patent centrality and the method to estimate the yearly technology performance improvement rate (TIR) that underly that study. Some of this data (performance time series and the lists of patents for 28 domains) has been collected by other authors for previous studies but were previou ...[more]

PMID: 32964078

Similar Datasets

Project description:Multi-morbidity, the health state of having two or more concurrent chronic conditions, is becoming more common as populations age, but is poorly understood. Identifying and understanding commonly occurring sets of diseases is important to inform clinical decisions to improve patient services and outcomes. Network analysis has been previously used to investigate multi-morbidity, but a classic application only allows for information on binary sets of diseases to contribute to the graph. We propose the use of hypergraphs, which allows for the incorporation of data on people with any number of conditions, and also allows us to obtain a quantitative understanding of the centrality, a measure of how well connected items in the network are to each other, of both single diseases and sets of conditions. Using this framework we illustrate its application with the set of conditions described in the Charlson morbidity index using data extracted from routinely collected population-scale, patient level electronic health records (EHR) for a cohort of adults in Wales, UK. Stroke and diabetes were found to be the most central single conditions. Sets of diseases featuring diabetes; diabetes with Chronic Pulmonary Disease, Renal Disease, Congestive Heart Failure and Cancer were the most central pairs of diseases. We investigated the differences between results obtained from the hypergraph and a classic binary graph and found that the centrality of diseases such as paraplegia, which are connected strongly to a single other disease is exaggerated in binary graphs compared to hypergraphs. The measure of centrality is derived from the weighting metrics calculated for disease sets and further investigation is needed to better understand the effect of the metric used in identifying the clinical significance and ranked centrality of grouped diseases. These initial results indicate that hypergraphs can be used as a valuable tool for analysing previously poorly understood relationships and information available in EHR data.

Project description:Motion capture laboratories can measure multiple variables at high frame rates, but we can only measure the average metabolic rate of a stride using respiratory measurements. Biomechanical simulations with equations for calculating metabolic rate can estimate the time profile of metabolic rate within the stride cycle. A variety of methods and metabolic equations have been proposed, including metabolic time profile estimations based on joint parameters. It is unclear whether differences in estimations are due to differences in experimental data or due to methodological differences. This study aimed to compare two methods for estimating the time profile of metabolic rate, within a single dataset. Knowledge about the consistency of different methods could be useful for applications such as detecting which part of the gait cycle causes increased metabolic cost in patients. Here we compare estimations of metabolic rate time profiles using a musculoskeletal and a joint-space method. The musculoskeletal method was driven by kinematics and electromyography data and used muscle metabolic rate equations, whereas the joint-space method used metabolic rate equations based on joint parameters. Both estimations of changes in stride average metabolic rate correlated significantly with large changes in indirect calorimetry from walking on different grades showing that both methods accurately track changes. However, estimations of changes in stride average metabolic rate did not correlate significantly with more subtle changes in indirect calorimetry due to walking with different shoe inclinations, and both the musculoskeletal and joint-space time profile estimations did not correlate significantly with each other except in the most downward shoe inclination. Estimations of the relative cost of stance and swing matched well with previous simulations with similar methods and estimations from experimental perturbations. Rich experimental datasets could further advance time profile estimations. This knowledge could be useful to develop therapies and assistive devices that target the least metabolically economic part of the gait cycle.

Project description:We introduce a microfluidic platform that enables single-cell mass and growth rate measurements upstream of single-cell RNA-sequencing (scRNA-seq) to generate paired single-cell biophysical and transcriptional data sets. Biophysical measurements are collected with a serial suspended microchannel resonator platform (sSMR) that utilizes automated fluidic state switching to load individual cells at fixed intervals, achieving a throughput of 120 cells per hour. Each single-cell is subsequently captured downstream for linked molecular analysis using an automated collection system. From linked measurements of a murine leukemia (L1210) and pro-B cell line (FL5.12), we identify gene expression signatures that correlate significantly with cell mass and growth rate. In particular, we find that both cell lines display a cell-cycle signature that correlates with cell mass, with early and late cell-cycle signatures significantly enriched amongst genes with negative and positive correlations with mass, respectively. FL5.12 cells also show a significant correlation between single-cell growth efficiency and a G1-S transition signature, providing additional transcriptional evidence for a phenomenon previously observed through biophysical measurements alone. Importantly, the throughput and speed of our platform allows for the characterization of phenotypes in dynamic cellular systems. As a proof-of principle, we apply our system to characterize activated murine CD8+ T cells and uncover two unique features of CD8+ T cells as they become proliferative in response to activation: i) the level of coordination between cell cycle gene expression and cell mass increases, and ii) translation-related gene expression increases and shows a correlation with single-cell growth efficiency. Overall, our approach provides a new means of characterizing the transcriptional mechanisms of normal and dysfunctional cellular mass and growth rate regulation across a range of biological contexts.

Dataset Information

Functional performance improvement data and patent sets for 30 technology domains with measurements of patent centrality and estimations of the improvement rate.

Publications

Functional performance improvement data and patent sets for 30 technology domains with measurements of patent centrality and estimations of the improvement rate.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets